Sialidase inhibitors with different mechanisms

JM Keil, GR Rafn, IM Turan, MA Aljohani… - Journal of medicinal …, 2022 - ACS Publications
Sialidases, or neuraminidases, are enzymes that catalyze the hydrolysis of sialic acid (Sia)-
containing molecules, mostly removal of the terminal Sia (desialylation). By desialylation …

[HTML][HTML] Neuraminidase-1: A novel therapeutic target in multistage tumorigenesis

F Haxho, RJ Neufeld, MR Szewczuk - Oncotarget, 2016 - ncbi.nlm.nih.gov
Several of the growth factors and their receptor tyrosine kinases (RTK) such as epidermal
growth factor (EGF), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF) …

Thymoquinone alleviates the experimentally induced Alzheimer's disease inflammation by modulation of TLRs signaling

YS Abulfadl, NN El-Maraghy… - Human & …, 2018 - journals.sagepub.com
Alzheimer's disease (AD) is characterized by a robust inflammatory response elicited by the
accumulation and deposition of amyloid-β (Aβ) within the brain. Aβ induces detrimental …

[HTML][HTML] Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for Toll-like receptor activation and cellular signaling

S Abdulkhalek, SR Amith, SL Franchuk… - Journal of Biological …, 2011 - ASBMB
The signaling pathways of mammalian Toll-like receptors (TLRs) are well characterized, but
the precise mechanism (s) by which TLRs are activated upon ligand binding remains poorly …

NEU4 inhibits motility of HCC cells by cleaving sialic acids on CD44

X Zhang, P Dou, ML Akhtar, F Liu, X Hu, L Yang… - Oncogene, 2021 - nature.com
Hepatocellular carcinoma (HCC) is an extremely metastatic tumor. Sialic acids (SAs) are
associated with cancer development and metastasis. NEU4 is a sialidase that removes SAs …

[HTML][HTML] A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer

AM Gilmour, S Abdulkhalek, TSW Cheng, F Alghamdi… - Cellular signalling, 2013 - Elsevier
Epidermal growth factor (EGF)-induced EGFR tyrosine kinase receptor activation in cancer
cell survival responses has become a strategic molecular-targeting clinical therapeutic …

[HTML][HTML] Mammalian neuraminidases in immune-mediated diseases: mucins and beyond

EP Lillehoj, IG Luzina, SP Atamas - Frontiers in immunology, 2022 - frontiersin.org
Mammalian neuraminidases (NEUs), also known as sialidases, are enzymes that cleave off
the terminal neuraminic, or sialic, acid resides from the carbohydrate moieties of glycolipids …

Therapeutic potential of thymoquinone in glioblastoma treatment: Targeting major gliomagenesis signaling pathways

FA Chowdhury, MK Hossain… - BioMed research …, 2018 - Wiley Online Library
Glioblastoma multiforme (GBM) is one of the most devastating brain tumors with median
survival of one year and presents unique challenges to therapy because of its aggressive …

[HTML][HTML] Neu1 sialidase and matrix metalloproteinase-9 cross-talk regulates nucleic acid-induced endosomal TOLL-like receptor-7 and-9 activation, cellular signaling …

S Abdulkhalek, MR Szewczuk - Cellular Signalling, 2013 - Elsevier
The precise mechanism (s) by which intracellular TOLL-like receptors (TLRs) become
activated by their ligands remains unclear. Here, we report a molecular organizational G …

Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for neurotrophin activation of Trk receptors and cellular signaling

P Jayanth, SR Amith, K Gee, MR Szewczuk - Cellular signalling, 2010 - Elsevier
Neurotrophin-induced Trk tyrosine kinase receptor activation and neuronal cell survival
responses have been reported to be under the control of a membrane associated sialidase …